Curis (CRIS) Accumulated Expenses (2010 - 2026)
Curis' (CRIS) quarterly Accumulated Expenses came in at $7.0 million in Q1 2026, up 8.1% YoY from $6.5 million in Q1 2025, and down 3.73% on a QoQ basis from $7.3 million in Q4 2025.
Curis (CRIS) Accumulated Expenses (2010 - 2026) Analysis & Trends
Curis (CRIS) has 17 years of Accumulated Expenses data on file, last reported at $7.0 million in Q1 2026.
- Quarterly Accumulated Expenses rose 8.1% year-over-year to $7.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $7.0 million (up 8.1% YoY) and the FY2025 annual result came in at $7.3 million, up 2.29% from the prior year.
- Accumulated Expenses declined to $7.0 million in Q1 2026, from $7.3 million in the prior quarter.
- In the past five years, Accumulated Expenses ranged from a high of $9.0 million in Q4 2023 to a low of $4.2 million in Q1 2023.
- A 5-year average of $6.6 million and a median of $6.7 million in 2024 frame the typical range for Accumulated Expenses.
- Annual changes were most pronounced in 2022 — Accumulated Expenses jumped 122.41% — and 2024, when it retreated 21.34%.
- Tracing CRIS's Accumulated Expenses over 5 years: stood at $5.7 million in 2022, then surged by 59.18% to $9.0 million in 2023, then dropped by 21.34% to $7.1 million in 2024, then gained by 2.29% to $7.3 million in 2025, then fell by 3.73% to $7.0 million in 2026.
- The last three Accumulated Expenses figures came in at $7.0 million (Q1 2026), $7.3 million (Q4 2025), and $7.3 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Curis | 3.27 Mn | -2.35 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.00 Mn |
| Dec 31, 2025 | 7.27 Mn |
| Sep 30, 2025 | 7.29 Mn |
| Jun 30, 2025 | 6.66 Mn |
| Mar 31, 2025 | 6.48 Mn |
| Dec 31, 2024 | 7.11 Mn |
| Sep 30, 2024 | 8.14 Mn |
| Jun 30, 2024 | 6.74 Mn |
| Mar 31, 2024 | 6.33 Mn |
| Dec 31, 2023 | 9.04 Mn |
| Sep 30, 2023 | 7.23 Mn |
| Jun 30, 2023 | 5.78 Mn |
| Mar 31, 2023 | 4.25 Mn |
| Dec 31, 2022 | 5.68 Mn |
| Sep 30, 2022 | 6.88 Mn |
| Jun 30, 2022 | 5.58 Mn |
| Mar 31, 2022 | 4.59 Mn |
| Dec 31, 2021 | 6.34 Mn |
| Sep 30, 2021 | 5.31 Mn |
| Jun 30, 2021 | 3.18 Mn |